Bacillus velezensis GFZF-23 Alleviates Colitis through Microbiome Restoration and β-Sitosterol-Mediated Metabolic Reprogramming
This study demonstrates that *Bacillus velezensis* GFZF-23 alleviates colitis by restoring microbiome homeostasis in conventional hosts and directly reprogramming host metabolism via -sitosterol in germ-free conditions, utilizing a reverse screening platform to disentangle these distinct therapeutic mechanisms.